Although aortic-to-brachial pulse pressure amplification (PPamp) may offer prognostic information beyond brachial blood pressure (BP), this approach is limited in resource-limited settings. We aimed to derive an equation to impute central aortic PP (PPc) from simple clinical measures and assess whether imputed PPamp adds to the ability of brachial BP to predict mortality.
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Although pulse pressure (PP) measured at the brachial artery (PPb) is closely correlated with central aortic PP (PPc), considerable amplification of PP may occur from the aorta to brachial arteries. 1, 2 As there may be marked differences in aortic vs. brachial blood pressure (BP) 1, 2 and because of the close proximity of the aorta to end organs, aortic BP has been proposed to be of greater pathophysiological significance than brachial BP. Indeed some, [3] [4] [5] [6] [7] [8] [9] [10] [11] but not other 12, 13 studies have demonstrated that PPc or the aortic-to-brachial amplification ratio (PPamp) are associated with cardiovascular outcomes beyond brachial BP. Therefore, aortic BP measurements may ultimately be used to add to the ability of brachial BP to predict risk. However, the current cost of devices employed for noninvasive aortic BP measurements precludes their routine use at a primary care level in resource-limited settings.
One possible solution to the potential high costs of noninvasive aortic BP measurement may be to impute PPc from routinely attained clinical measures. 14 Indeed, the major determinants of PPc [14] [15] [16] are normally acquired as part of standard risk prediction. Thus, deriving an imputation equation from multivariate modeling 14 and applying this equation to routinely acquired clinical measures may serve as an approximate of aortic PPc. In this regard, aortic BP imputed from simple clinical measurements closely correlates with pulse wave analysis-derived aortic BP with minimal mean differences. 9, 10 Nevertheless, mean arterial pressure (MAP) and pulse rate, 2 of the principle determinants of PPc [14] [15] [16] were not included in the imputation equation for PPc. 9, 10 We therefore aimed to identify an imputation equation that incorporates MAP and pulse rate that closely approximates PPc and subsequently to determine whether imputed PPc or PPamp add to the ability of brachial BP to predict all-cause mortality. We assessed relations between imputed ambulatory awake rather than in-office PPc or PPamp and mortality as we did not have access to accurate office pulse rate data for the imputation of PPc or PPamp.
METHODS

Study samples
The present studies were conducted according to the principles outlined in the Helsinki declaration. The Committee for Research on Human Subjects of the University of the Witwatersrand approved the protocols for a communitybased study (approval number: M02-04-72 renewed as M07-04-69 and M12-04-108) and the Committee for Research on Human Subjects of the Hadassah-Hebrew University Medical Centers approved the protocol for the outcomes-based study.
To derive an appropriate imputation equation, 1,179 participants older than 16 years were randomly recruited from the South West Township (SOWETO), Johannesburg, South Africa, as previously described. [17] [18] [19] [20] Of these participants, 788 had 24-hour ambulatory BP measurements that met with prespecified quality control criteria. [17] [18] [19] We validated the imputation equation in 351 patients derived from several clinical samples (217 with critical limb ischemia, 89 with renal failure requiring dialysis, and 45 with severe or refractory hypertension), 248 of whom were of black African origins and 103 of whom were of European, Asian, and mixed ancestry. Participants gave informed, written consent. To evaluate relationships between awake ambulatory PPc or PPamp and all-cause mortality, data were extracted from an ambulatory BP service database in Jerusalem, Israel 21, 22 and the aortic BP imputation equation applied to ambulatory awake BP data. Participants were not required to give consent due to the service nature of the cohort. Data from 1991 to 31 May 2011 were extracted and 4,796 of 4,843 consecutive patients' records were included. Forty-eight patient records (1%) were excluded due to missing data on mortality predictors (see below). Mortality data were obtained by linkage with the national population register by way of individual national identification numbers. No information on cause of death was available.
Aortic blood pressure measurements
To derive an appropriate imputation equation, in the community-based study aortic BP was determined using radial applanation tonometry and a validated transfer function incorporated in SphygmoCor software (version 6.21, AtCor Medical Pty, West Ryde, New South Wales, Australia) as previously described. [18] [19] [20] After participants had rested for 15 minutes in the supine position, arterial waveforms at the radial (dominant arm) pulse were recorded by applanation tonometry during an 8-second period using a high-fidelity SPC-301 micromanometer (Millar Instrument, Houston, TX) interfaced with a computer employing SphygmoCor, version 9.0 software (AtCor Medical Pty). Recordings where the systolic or diastolic variability of consecutive waveforms exceeded 5% or the amplitude of the pulse wave signal was less than 80 mV were discarded. All measurements were made by a single, experienced, trained technician unaware of the clinical history of the participants. To determine aortic BP, the pulse wave was calibrated by manual measurement (auscultation) of brachial BP taken immediately before the recordings. From an inbuilt generalized transfer function (GTF) an aortic waveform was generated from which central aortic systolic (SBPc) and diastolic BP (DBP) were derived. Central aortic SBP was also determined from the peak pressure of the second pressure wave of the radial pulse wave (P2). 19 Both GTF-and P2-derived PPc were calculated as SBPc-DBP. Both GTF-and P2-derived PPc were determined as P2-derived aortic BP does not depend on the use of a GTF and there is uncertainty as to whether the application of a GTF to derive central pressures is appropriate for both sexes and all disease groups. 19 MAP was calculated as brachial DBP + (1/3 (brachial SBP-DBP)), or from the brachial form factor (MAP-DBP)/PPb, where MAP was obtained from SphygmoCor software and was derived from the area under the radial pulse wave calibrated to brachial BP. The brachial form factor was employed to determine the average of the brachial waveform independent of absolute BP. 15 To avoid obtaining negative aortic AIx values in young participants, AIx was determined as the pressure at the second systolic peak of the aortic pulse wave/the pressure at the first systolic peak of the aortic pulse wave expressed as a percentage.
Derivation of imputation equation
To derive an appropriate imputation equation, multiple linear regression analysis was performed to identify the factors that account for most of the variation in radial pulse wave-derived PPc. The β-coefficient for each factor was employed to derive the final equation. To determine the appropriateness of the imputation equation, the correlation coefficients and slopes of the imputed vs. pulse wave-derived PPc relationships were evaluated and the mean ± 2SDs for the imputed vs. pulse wave-derived PPc values were compared using Bland-Altman analysis in the population from which the equation was derived, subgroups of the population from which the equation was derived, and in the separate clinical population (external validation).
Ambulatory awake PPc and PPamp
The PPc imputation equation was applied to ambulatory awake BP and pulse rate measurements and awake PPamp was calculated as awake PPb/awake PPc. Spacelabs model 90207 ambulatory BP monitors were employed and monitors were programmed to record values as previously described. 21, 22 Awake periods were identified from diary cards. 21, 22 
Data analysis
To determine the factors that account for variations in SphygmoCor-derived PPc, multivariate linear regression analysis was performed with appropriate adjustments using SAS version 9.1 (SAS Institute, Cary, NC). Hazards ratios for mortality of awake PPc or PPamp were computed by Cox regression using R ("survival") package. In multiple Cox regression models, we included age, sex, body mass index, treatment for hypertension, treatment for diabetes, and the specified ambulatory BP-related parameters. Age was used as an exponential term because of better fit with mortality. 21, 22 Body mass index was fitted to spline smoothing due to bimodal association with mortality. 23 Ambulatory awake pulse rate was not included as an adjustor as it was not associated with all-cause mortality.
RESULTS
Clinical and demographic characteristics
The characteristics of the participants are shown in Table 1 . In the community-based sample 1.5% had a history of cardiovascular disease.
Imputing PPc
The factors most strongly associated with pulse wavederived PPc were PPb, age, pulse rate (obtained from SpygmoCor), MAP, and female gender ( Table 2 , left panel). As brachial PP, age, pulse rate, and MAP accounted for the majority of the variation (96%) in pulse wave-derived PPc, the imputation equation was derived from the β-coefficients of the relationships between these 4 factors and pulse wave-derived PPc (Table 2 , right panel). Although brachial PP was closely correlated with pulse wave-derived PPc ( Figure 1 , upper left panel, Table 2 ), brachial PP consistently overestimated PPc with a greater bias toward a lower PPc as compared to brachial PP at higher PPc values ( Figure 1 , lower left panel). Imputing PPc from the size effects of PPb, age, pulse rate, and MAP using the formula given in the footnote to Table 3 , generated a relationship between imputed PPc and pulse wave-derived PPc with an improved correlation coefficient, slope, and intercept ( Figure 1 , upper right panel and Table 3 (all participants)), with a markedly reduced mean difference ( Figure 1 , lower right panel and Table 3 (all participants)) and no bias toward a lower PPc as compared to brachial PP at higher PPc values ( Figure 1 , lower right panel and Table 3 (all participants)).
The addition of sex to the PPc imputation equation resulted in a greater mean (±2SD) difference (−4.20 ± 5.80) between imputed PPc and pulse wave-derived PPc than that achieved without the addition of sex to the model (P < 0.0001 for comparisons of mean differences). The exclusion of pulse rate and MAP from the PPc imputation equation also generated a greater mean (±2SD) difference between imputed and pulse wave-derived PPc values (−6.5 ± 7.9, P < 0.0001 vs. with pulse rate and MAP). The inclusion of the brachial form factor, rather than MAP, failed to improve the mean (±2SDs) differences between pulse wave-derived and imputed PPc (−11.6 ± 5.0 mm Hg). The addition of body height, treatment for hypertension or smoking failed to improve the correlation coefficients, or slopes of the imputed vs. pulse wavederived PPc relationships or the mean differences between these values (data not shown). The relationship between imputed PPc and P2-derived, rather than GTF-derived PPc showed a similar correlation coefficient (0.94), slope (0.990 ± 0.007), intercept (−1.22 ± 0.29), and mean difference ±2SD (−1.61 ± 7.63). The characteristics of the relationships and mean (±2SD) differences between imputed PPc and pulse wave-derived PPc were similar in men and women, in those with an increased waist circumference, hypertensives, those with diabetes mellitus, and in smokers (Table 3 ). In addition, the characteristics of the relationships and mean (±2SD) differences between imputed PPc and pulse wave-derived PPc were similar in those with or without an in-office white-coat response (office SBP or DBP>day SBP or DBP), and in those with or without office SBP measured to within 5 mm Hg of ambulatory awake SBP (reflecting in-part accurate as opposed to inaccurate office BP measurements) (Table 3) . Furthermore, the characteristics of the relationships and mean (±2SD) differences between imputed PPc and pulse wave-derived PPc were similar to all participants in those with a PPc ≥ 50 mm Hg (Table 3) , where a greater bias toward a lower PPc as compared to brachial PP was noted (Figure 1, lower left panel) . The mean (±2SD) differences between imputed PPc and pulse wave-derived PPc were similar below (−2.9. ± 6.14 mm Hg) and above (0.16 ± 4.54 mm Hg) the median of AIx (140.2). However, the slope (β-coefficient) of the relationship between imputed PPc and pulse wave-derived PPc was reduced in those with an AIx below (0.86 ± 0.01) as compared to above (1.00 ± 0.006 mm Hg) the median value (140.2). Nevertheless this difference was largely attributed to the slope of the relationship between brachial PP and pulse wave-derived PPc being reduced in those with an AIx below (0.73 ± 0.01) as compared to above (0.89 ± 0.005 mm Hg) the median value (140.2) rather than an inability of the imputation equation to improve on the slope.
Imputed vs. pulse wave-derived PPc in clinical sample
As with the community-based sample, in the clinical population, brachial PP was closely correlated with pulse wavederived PPc (r 2 = 0.882), but consistently overestimated PPc with a greater bias toward a lower PPc as compared to brachial PP at higher PPc values (slope = 0.82 ± 0.02, mean difference ± 2 × SD = −12.48 ± 12.32 mm Hg). Imputing PPc using the formula given in Table 3 , generated a relationship between imputed PPc and pulse wave-derived PPc in the clinical sample with an improved correlation coefficient (r 2 = 0.943), and slope (0.96 ± 0.01) with a markedly reduced mean difference ± 2 × SD (−2.17 ± 7.44 mm Hg) (P < 0.0001 for comparisons of r 2 , β-coefficient and mean difference). The relationship between imputed PPc and pulse wavederived PPc in those of European, Asian, and mixed ancestry showed a similar correlation coefficient (r 2 = 0.946), slope (β-coefficient = 0.964 ± 0.023) and mean difference ± 2SD (−2.50 ± 7.54 mm Hg) as did the relationship between imputed PPc and pulse wave-derived PPc in those of black African ancestry (r 2 = 0.941, slope = 0.957 ± 0.015, mean difference ± 2 × SD = −2.03 ± 7.38 mm Hg). 
Imputed aortic pressure predicts mortality
In the outcome study, median duration of follow-up was 9.8 years (25th-75th percentile: 5.2-14.5 years). Fatal events occurred in 648/4,796 patients during 47,111 person-years of follow-up (incidence rate: 13.8 deaths per 1,000 personyears). Persons who died before the linkage data date were older (68 ± 12 vs. 54 ± 15 years, P < 0.0001) and had a higher prevalence of antihypertensive treatment (80% vs. 56%, P < 0.0001) and treated diabetes mellitus (16.9% vs. 8.2%, P < 0.0001) than those alive at the end of follow-up.
In multiple Cox regression models ambulatory awake brachial PP and SBP predicted all-cause mortality (Figure 2 , upper panel, Table 4 ) with ambulatory awake brachial PP being a better predictor of all-cause mortality than ambulatory awake brachial SBP (Table 4 ). In addition, ambulatory awake PPamp predicted all-cause mortality independent of ambulatory awake brachial PP and MAP or ambulatory awake brachial SBP and MAP and other confounders ( Figure 2 , Table 4 ). Importantly, ambulatory awake PPamp independently predicted all-cause mortality without decreasing the magnitude of risk prediction by awake brachial PP or SBP (Table 4) . Ambulatory awake PPc also predicted all-cause mortality independent of ambulatory awake brachial PP and MAP or ambulatory awake brachial SBP and MAP and other confounders. However, in keeping with a low concordance rate between PPamp and PPc across each of their quartiles (Supplementary Table 1) , the inclusion of PPc in the models eliminated ambulatory awake brachial PP or SBP as risk predictors, rather than introducing an added predictive value (Table 4) .
DISCUSSION
The main findings of the present study are as follows: In a large community-based sample we identified an equation that incorporates the simple clinical measures of age, PPb, MAP, and pulse rate and which generates imputed PPc values that closely approximate pulse wave analysis-derived PPc values. Second, this equation was validated when applied to a clinical sample consisting of patients with severe and refractory hypertension, critical limb ischemia, and renal failure and performed equally as well in those of black African origins as in those of other ethnic origins. Third, when applying this imputation equation to ambulatory awake PPb, MAP, Figure 2 . Cox regression survival curves according to quartiles of ambulatory awake brachial pulse pressure (awake PPb) (upper panel) or imputed aortic-to-brachial pulse pressure amplification ratio (PPamp)(lower panel) in 4,796 patients referred for ambulatory blood pressure monitoring with 648 deaths. The upper panel is adjusted for age, gender, treated diabetes mellitus, treated hypertension, and body mass index. The lower panel is adjusted for the same confounders and ambulatory awake PPb and brachial mean arterial pressure. All-cause mortality hazards ratios (HR) for highest 2 quartiles as compared to the lowest quartile of PPb are 3rd quartile = 1.35 (95% confidence interval (CI): 0.96-1.89), P = 0.08, 4th quartile = 2.08 (95% CI: 1.50-2.87), P < 0.0001. All-cause mortality hazards ratios (HR) for the highest 2 quartiles as compared to the lowest quartile of PPamp are 3rd quartile = 0.80 (95% CI: 0.62-1.02), P = 0.08, 4th quartile = 0.55 (95% CI: 0.38-0.81), P < 0.005. Probability value for trend effects in the upper panel P < 0.0001; and in the lower panel P = 0.0026.
and pulse rate data, we noted that ambulatory awake PPamp, determined from imputed awake PPc predicted all-cause mortality independent of ambulatory awake brachial PP, SBP, and MAP, and that ambulatory awake PPamp added to the ability of ambulatory awake PP or SBP to predict mortality.
Prior studies where PPc was imputed from an equation, although demonstrating independent relationships between imputed PPamp and outcomes, failed to include MAP and pulse rate in the imputation equation. 9, 10 In contrast to these studies 9, 10 where only 85.8% of the variation in PPc could be accounted for, in the present study we could account for 97.5% of the variation in aortic BP, 96% of which was attributed to brachial PP, age, pulse rate, and MAP. Importantly, in the present study we show that without pulse rate and MAP included in the model, imputed PPc remained markedly lower than pulse wave-derived PPc. The present study therefore underscores the importance of pulse rate and MAP as determinants of central aortic BP. Indeed, prior studies have demonstrated that the differential effects of β-adrenoreceptor blocker-based as compared to alternative antihypertensive therapy on cardiovascular outcomes, may be attributed inpart to an attenuated beneficial effect of heart rate-lowering therapy on aortic BP. 8, 24 Although from the present study we cannot draw conclusions as to whether PPamp is a better predictor of mortality than PPc; we are able to show that PPamp adds to the ability of PPb to predict outcomes, whereas PPc replaces PPb. The differential impact of imputed PPc and PPamp on mortality when included in the same Cox models with brachial BP, which is supported by the low concordance rate between PPamp and PPc across each of their quartiles, warrants consideration. In this regard, forward wave pressures determine both PPc and PPb. Hence, PPc and PPb show a high degree of colinearity. In contrast, PPamp may largely be an index of backward wave pressure effects. That is, because there is a time delay in the backward wave arriving at the brachial or radial artery, the backward wave contributes toward the tidal wave (second systolic shoulder) rather than the percussion wave (peak systolic brachial pressure) of the brachial pulse and hence may not contribute toward brachial PP except in the very elderly when the timing of the backward wave may be sufficiently early that the percussion and tidal waves occur together. Thus, when assessing relations with mortality, the inclusion of PPc (forward and backward wave effects) and brachial BP (largely forward wave effects) in the same model results in relations between PPc and mortality being retained, but eliminates relations between brachial PP and mortality. Simply replacing brachial BP with aortic BP is obviously not desirable when risk predicting, as brachial BP is a well-established risk predictor. In contrast, the inclusion of PPamp (largely backward wave effects) and brachial BP (largely forward wave effects) in the same model results in relations between both brachial PP and PPamp and mortality being retained, without attenuating the strength of brachial PP as a risk predictor. The present results therefore highlight the ability of PPamp to add to the ability of brachial BP to predict outcomes.
Although there are several studies that have demonstrated an independent or better effect of PPc or PPamp as compared to brachial BP on outcomes 3-11 the Framingham Heart Study failed to show similar relations. 13 However, the Framingham Heart Study was conducted in participants where little agerelated increase in backward wave pressure was noted. 25 This is in contrast to large community-based studies which show marked age-related increases in backward wave pressures. 26, 27 As the difference between PPc and brachial BP may largely be determined by backward wave pressures, it is therefore not surprising that PPamp failed to add to the ability of brachial BP to predict risk in the Framingham Heart Study. 13 An important caveat of the present study is that our results do not suggest that PPamp derived from imputed PPc may replace PPamp derived from noninvasively measured PPc in risk prediction. In this regard, in those with a lower augmentation index (younger individuals), largely because the slope of the relationship between brachial PP and PPc is reduced, the slope (β-coefficient) of the relationship between imputed PPc and pulse wave-derived PPc is further from A number of limitations of the present study require consideration: As we did not have access to in-office pulse rate data for a significant number of participants in the outcomesbased study, we employed ambulatory awake BP and pulse rate data to estimate imputed PPc. We nevertheless first confirmed that the imputation equation applied equally well in those with or without an in-office white-coat response (office SBP or DBP>day SBP or DBP), and in those with or without office SBP measured to within 5 mm Hg of ambulatory awake SBP (reflecting in-part accurate as opposed to inaccurate office BP measurements). Second, calibration of the radial waveform from brachial BP measurements ignores amplification of BP from brachial to radial arteries. Hence, aortic pressures are likely to have been underestimated using the current approach. Third, we did not have access to cause of death or to nonfatal cardiovascular outcomes, and hence further studies are required to confirm the brachial BP-independent role of PPamp derived from imputed PPc as a predictor of cardiovascular events. Fourth, to assess outcomes we studied referred patients who may not be representative of general or hypertensive populations. However, the current study is more representative of daily clinical practice. Fifth, whereas the community study was of black African ancestry, the outcome cohort consisted of Israeli's, the vast majority of whom are of European or Mid-Eastern ethnicity. However, in the clinical cohort employed for external validation we noted that the imputation equation applied equally well in those of European, Asian, and mixed ancestry as it did in the group of black African origins. Nonetheless, augmentation index is increased in groups of black African ancestry. 28 Further, the imputation equation, at lower augmentation indexes, does not produce a slope (0.89) of the pulse wave derived and imputed PPc relation that closely approximates unity. Hence, we may have underestimated the impact of aortic PPc and PPamp derived from an imputation equation on mortality by applying the equation to a population that is more likely to have a lower AIx. Sixth, in the outcome study we did not have access to all information on risk factors (smoking and dyslipidemias), and hence we could not evaluate whether awake PPamp derived from imputed PPc predicts outcomes independent of these risk factors. Nevertheless, as smoking only explains 0.03% of aortic PP and total cholesterol was not independently associated with aortic PP (P = 0.96), it is unlikely that either smoking or total cholesterol would make an impact on relations between imputed PPamp and outcomes.
In conclusion, in the present study we show that aortic PP can be imputed from an equation that employs simple clinical measures (age, brachial PP, MAP, and pulse rate) and that imputed aortic PP produces values that closely approximate noninvasively determined aortic PP (applanation tonometry and SphygmoCor software). In addition, we show that PP amplification derived from aortic PP imputed from this equation as applied to ambulatory awake BP and pulse rate data, adds to the ability of brachial BP to predict mortality. In view of the cost of devices designed to measure aortic BP noninvasively, aortic BP imputed from simple clinical measures may be of value when risk predicting in resource-limited settings.
SUPPLEMENTARY MATERIAL
Supplementary materials are available at American Journal of Hypertension (http://ajh.oxfordjournals.org).
